Introduction 42
Propofol is widely used for induction of general anaesthesia in dogs but commonly 43 produces both cardiovascular and respiratory depression (Nakaigawa et al. 1995; Muir & 44 Gadawski 1998). While the latter can be managed using intermittent positive pressure 45 ventilation, the cardiovascular effects, primarily vasodilatation at the usual clinical doses, 46 are more clinically challenging (Goodchild & Serrao 1989) . Although these effects aregenerally well tolerated by healthy dogs, those with any degree of pre-existing 48 cardiovascular compromise may be unable to compensate for these changes. 49
Propofol target-controlled infusion (PTCI) has been used for induction and maintenance of 50 anaesthesia in dogs (Beths et al. 2001 ; Musk et al. 2005 ). This technique employs a 51 software-controlled syringe pump that delivers propofol as a variable rate infusion to 52 achieve and maintain a user-selected plasma target concentration, which is based on 53 population pharmacokinetic parameters and patient factors including body weight. The 54 predicted plasma target concentration of propofol for induction of general anaesthesia in 55 dogs ranges from 3 to 6 µg mL 
2009). 56
This range is similar to that reported in man (White & Kenny 1990) . One recognized 57 benefit of PTCI for induction of anaesthesia is that this technique allows a gradual increase 58 in the plasma concentration as compared with manually controlled infusion techniques 59 (Struys et al. 1997 ). This may potentially result in less cardiovascular depression (Stokes & 60 Hutton 1991) . 61
Using a 'co-induction' technique can also potentially lessen the cardiovascular-depressant 62 effects of propofol. Co-induction refers to the administration of a sedative, anaesthetic or 63 analgesic drug along with the main hypnotic agent to reduce the dose of induction agent 64 required (Armein et al. 1995) . To achieve a beneficial effect from co-induction, the drug 65 selected should not only have a hypnotic dose-sparing action but must have minimal 66 cardiovascular depressant effects of its own. 67
In human anaesthesia, the use of midazolam as a co-induction agent with propofol is well 68 Haematology and serum biochemistry were carried out in some but not all dogs depending 105 on the preference of the individual clinician referring the dog for anaesthesia. Dogs were 106 not considered eligible if brachycephalic, significantly overweight, younger than 6 months 107 or older than 8 years of age, receiving opioid analgesic medication or with a history of 108 vomiting/regurgitation or respiratory obstruction. 109
Study protocol 110
For the purpose of the study, dogs were randomly assigned to one of three groups prior to 111 premedication (n = 20 for each group) using a computer-generated random numbers list Pre-oxygenation via a facemask connected to a coaxial Bain breathing system (Intersurgical 133 Ltd, UK) was commenced at a flow rate of 200 mL kg -1 minute -1 for at least 3 minutes 134 before induction of general anaesthesia and was continued until successful intubation. 135
Propofol TCI was administered via a syringe driver (Graseby 3500 Anaesthesia Pump; 136 SIMS Graseby Ltd, UK) incorporating a 'PK-Fusor for propofol 10 mg mL -1 in dogs' 137 software. The age and body weight of the dog were entered into the device, and a propofol 138 plasma target concentration of 1 µg mL -1 was selected. Propofol TCI was then started. At 139 example, patient excitement, was noted. Two minutes later, the dog was assessed to 142 determine if endotracheal intubation was possible by checking pre-established end points: 143 weakened palpebral reflex, rostromedial rotation of the eyeball, a reduction in jaw tone and 144 lack of tongue withdrawal. When these conditions were obtained, endotracheal intubation 145 was attempted. If these criteria were not met, the propofol plasma target concentration was 146 increased in a stepwise manner by 0.5 µg mL -1 each 60 seconds, reassessing the dog at 147 each new target until successful endotracheal intubation was achieved. The required 148 propofol target concentration was recorded. 149
Heart rate, f R , SAP, MAP and DAP were recorded just prior to commencing PTCI (B0), 150 prior to intubation (BI), immediately after (T0), and at 3 (T3) and 5 (T5) minutes post-151 endotracheal intubation. To measure the blood pressure, an inflatable cuff was applied to 152 the base of the tail, using a cuff width of approximately 40% of the circumference. The 153 blood pressure was measured four times: the first measurement was discarded and the 154 following three measurements were averaged to maximize the accuracy of the readings. 155
The end-tidal partial pressure of CO 2 (P E' CO 2 ) (Nellcor NPB-70; Mallinckrodt, 156 Netherland), and arterial haemoglobin oxygen saturation (SpO 2 ) (Nonin Model 9847V; 157 Nonin Medial, Inc., MN, USA) were also recorded immediately after (T0), and at 3 (T3) 158 and at 5 (T5) minutes post-intubation. If post-induction apnoea (defined as the absence of 159 spontaneous respiratory effort for at least 60 seconds) occurred, manual ventilation at a rate 160 of 2 breaths per minute was initiated until spontaneous ventilation resumed. The adjustable 161 pressure-limiting valve of the Bain breathing system was closed and the rebreathing bag 162 was manually squeezed to achieve a maximum peak inspiratory pressure of 20 cmH 2 O 163 during inspiration. 164
Once the data collection was completed, the PTCI was discontinued and general 165 anaesthesia was maintained according to the requirement of the procedure the dog was 166 undergoing. 167
Statistical analysis 168
Power analysis, based on data derived from a pilot study with 18 dogs in total, indicated 169 that a sample size of at least 18 dogs per group would detect a clinically significant 170 difference of 0.5 µg mL -1 for the predicted plasma target concentration of propofol for 171 induction of anaesthesia with a power of 80%. 172
Variables were checked for normality by examining box plots and histograms. Either the 173 mean or median values were used for statistical comparison of data between the groups. 174
Propofol target concentration data were analysed using Kruskal-Wallis and post-hoc 175
Mann-Whitney tests. The age, body weight, HR, MAP, f R , P E' CO 2 and SpO 2 were analysed 176 using t-tests and repeated measures analysis of variance (one-way and within a general 177 linear model framework). Chi-squared tests were used to examine the association between 178 categorical variables (sedation score, sex). All analyses were performed using Minitab 16 179 (Minitab Inc., UK). A p-value of < 0.05 was considered statistically significant. 180
Results

181
Demographics 182
Of the 60 dogs included in the study, 29 were male and 31 female, with a mean age of 183 48 ± 27 months and a mean body weight of 29 ± 9.7 kg. There were no differences between 184 the three groups with respect to age, body weight or sedation score after premedication. 
Cardiovascular variables 194
In the three groups, HR increased before intubation (BI) and after intubation (T0) compared 195
with B0 values and decreased at 3 (T3) and 5 minutes (T5) after intubation (Fig. 2a) In the three groups, the MAP increased before (BI) and after intubation (T0) compared with 202 B0 values and decreased at 3 (T3) and 5 minutes (T5) after intubation (Fig. 2b) . The mean 203 arterial pressure was significantly affected by time (p = 0.008) and subject variability 204 (p < 0.001) but not by the co-induction agent. There was no significant difference in the 205 change in MAP after intubation (T0) compared with before intubation (BI) between the 206 three groups. The mean change in MAP (95% CI) after intubation was +1.0 mmHg (-3.1 to 207 5.2) in MG, +6.0 mmHg (0.5 to 11.4) in LG and +2.3 mmHg (-1.7 to 6.2) in SG. 208
Respiratory variables 209
The respiratory rate was similar in the three groups at all time points. Values were lower 210 after intubation (T0) and increased by the end of the data collection (T5) in all groups. Post-211 induction apnoea was not observed in any of the dogs. The values of P E' CO 2 were similar inthe three groups at all time points. Recorded values were lower after intubation (T0) and 213 increased by the end of the data collection (T5) in all groups (Table 1) was too transient to be detected by an oscillometric blood pressure system. These findings 317 may support that administration of propofol to effect using a PTCI is already a technique 318 with clinically acceptable haemodynamic stability. 319
In the present study, the mean f R and P E' CO 2 were similar in the three groups at all time 320 
